Increased risk of early-onset preeclampsia in pregnant women with COVID-19

• Main Authors: Niraj N. Mahajan (Author), Shweta Kesarwani (Author), Padmaja Kumbhar (Author), Periyasamy Kuppusamy (Author), Madhura Pophalkar (Author), Pratiksha Thamke (Author), Ruchi Asawa (Author), Saumya Sharan (Author), Smita D Mahale (Author), Rahul K Gajbhiye (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Objective To estimate incidence, risk of early and late-onset preeclampsia (PE) and understand their relationship with severity of COVID-19. Methods Pregnant women with COVID-19 (n = 1929) were enrolled from 1 April 2020 to 24 February 2022. Primary outcome measure was incidence and risk of early onset PE in women with COVID-19. Results The incidence of early and late-onset PE was 11.4% and 5.6%. Moderate to severe COVID-19 was associated with eight times higher risk of early onset PE [aOR = 8.13 (1.56-42.46), p = 0.0129] compared to asymptomatic group. Conclusions Risk of early onset PE was higher in pregnant women with symptomatic COVID-19 as compared to asymptomatic women.

Item Description

1064-1955
1525-6065
10.1080/10641955.2023.2187630